A compound astragalus and ganoderma lucidum preparation with anticancer use and its preparation method and application

The compound Astragalus and Ganoderma lucidum preparation, designed using traditional Chinese medicine theory and network pharmacology, solves the problems of tumor recurrence, metastasis, and toxic side effects in existing treatments for malignant tumors, achieving anti-tumor effects and enhanced immunity, and improving bone marrow suppression caused by chemotherapy.

CN122124181APending Publication Date: 2026-06-02SHENYANG WANJIA INST OF BIOLOGICAL TECH RES
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SHENYANG WANJIA INST OF BIOLOGICAL TECH RES
Filing Date
2026-04-28
Publication Date
2026-06-02

AI Technical Summary

Technical Problem

Existing methods for treating malignant tumors have problems such as tumor recurrence and metastasis, drug resistance, and toxic side effects. In addition, conventional treatments severely damage the body's normal functions, leading to impaired immune function, bone marrow suppression, and digestive disorders. Traditional Chinese medicine has failed to effectively combine network pharmacology design in the prevention and treatment of tumors.

Method used

The compound Astragalus and Ganoderma lucidum preparation based on traditional Chinese medicine theory and network pharmacology contains Ganoderma lucidum, Astragalus membranaceus, Ganoderma lucidum spore powder, Panax notoginseng, Salvia miltiorrhiza, Atractylodes macrocephala, Smilax glabra, Hedyotis diffusa, Bombyx mori, and Glycyrrhiza uralensis. It is prepared by decoction and concentration, and after granulation, it forms an anticancer drug with multiple components and multiple targets, which enhances immunity and anti-tumor effects.

Benefits of technology

It significantly inhibits tumor growth, improves chemotherapy-induced leukopenia and thrombocytopenia in bone marrow transplantation, enhances immune function, reduces the risk of tumor recurrence, alleviates adverse reactions of chemotherapy, and enhances the body's anti-tumor immunity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122124181A_ABST
    Figure CN122124181A_ABST
Patent Text Reader

Abstract

This invention relates to the field of biomedicine. It provides a compound astragalus and ganoderma preparation with anti-cancer properties, its preparation method, and its application. The preparation is made from the following raw materials in parts by weight: 200-500 parts ganoderma, 200-500 parts astragalus, 50-100 parts ganoderma spore powder, 30-60 parts Panax notoginseng, 30-60 parts Salvia miltiorrhiza, 50-100 parts Atractylodes macrocephala, 150-300 parts Smilax glabra, 100-200 parts Hedyotis diffusa, 20-40 parts Bombyx mori, and 20-40 parts Glycyrrhiza uralensis. The compound astragalus and ganoderma preparation of this invention has anti-tumor effects and improves the effects of radiotherapy and chemotherapy on leukopenia and thrombocytopenia, as well as adverse reactions caused by anti-tumor treatment.
Need to check novelty before this filing date? Find Prior Art